Zevra therapeutics appoints thomas anderson to board of directors and announces retirement of matthew r. plooster

Celebration, fla., aug. 07, 2023 (globe newswire) -- zevra therapeutics (nasdaqgs: zvra) ("zevra" or “the company"), a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options, proudly welcomes tom anderson, a highly accomplished biopharma veteran, to its board of directors (the "board"). concurrently, the company announces the retirement of board member matthew r. plooster, whose valuable leadership has played a crucial role in shaping zevra's growth. both the announcement of the new director and mr. plooster's retirement are in accordance with the plan announced by the company on may 8, 2023.
ZVRA Ratings Summary
ZVRA Quant Ranking